Literature DB >> 12220887

Overexpression of TIAP/m-survivin in thymocytes enhances cell proliferation.

Satosi Hikita1, Masahiko Hatano, Atsushi Inoue, Nobuyuki Sekita, Koichi Kobayashi, Masayuki Otaki, Takeshi Ogasawara, Seiji Okada, Hiroyuki Hirasawa, Takeshi Tokuhisa.   

Abstract

TIAP/m-survivin, a member of the inhibitor of apoptosis (IAP) protein family, is expressed in a cell cycle dependent manner. It is strongly expressed in various subsets of thymocytes. To investigate a role of TIAP/m-survivin in thymocytes, mice carrying the lck-TIAP transgene were established. Two out of six transgenic mice expressed large amounts of TIAP mRNA and protein in thymocytes. Although T cell development and apoptosis of thymocytes were largely unaffected in lck-TIAP mice, transgenic thymocytes displayed hyperproliferation in response to PMA and ionomycin but not to anti-CD3 antibody. Thus, overexpression of TIAP/m-survivin augments cell proliferation of thymocytes to a certain stimulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220887     DOI: 10.1016/s0161-5890(02)00111-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

1.  Immunoexpression of Survivin in non-neoplastic lymphoid tissues and malignant lymphomas using a new monoclonal antibody reactive on paraffin sections.

Authors:  José Vassallo; Talal Al Saati; Randy D Gascoyne; Kathyrn Welsh; John C Reed; Pierre Brousset; Georges Delsol
Journal:  J Hematop       Date:  2010-01-30       Impact factor: 0.196

Review 2.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Distinct transcriptional programs in thymocytes responding to T cell receptor, Notch, and positive selection signals.

Authors:  Yina H Huang; Dongling Li; Astar Winoto; Ellen A Robey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.